Legato Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
11,129
-28,425
-72% -$3.44M 0.1% 304
2026
Q1
$6.47M Sell
39,554
-452
-1% -$69.5K 0.59% 21
2025
Q4
$6.96M Buy
40,006
+5,174
+15% +$944K 0.6% 18
2025
Q3
$5.02M Sell
34,832
-1,247
-3% -$153K 0.55% 33
2025
Q2
$3.63M Sell
36,079
-5,778
-14% -$442K 0.43% 43
2025
Q1
$3.19M Buy
41,857
+4,986
+14% +$381K 0.43% 45
2024
Q4
$2.55M Buy
36,871
+792
+2% +$57K 0.33% 60
2024
Q3
$2.63M Sell
36,079
-8,988
-20% -$663K 0.33% 64
2024
Q2
$3.02M Sell
45,067
-5,191
-10% -$201K 0.41% 43
2024
Q1
$1.36M Hold
50,258
0.16% 204
2023
Q4
$1.56M Hold
50,258
0.2% 156
2023
Q3
$1.27M Sell
50,258
-1,311
-3% -$30K 0.18% 186
2023
Q2
$1.09M Buy
51,569
+14,589
+39% +$277K 0.15% 235
2023
Q1
$631K Hold
36,980
0.11% 307
2022
Q4
$739K Buy
+36,980
New +$715K 0.14% 250

Other funds holding INSM

Legato Capital Management's INSM Position: Q2 2026 in Review

Legato Capital Management reduced its Insmed (INSM) stake by 72% in Q2 2026, selling an estimated $3.44M and leaving 11,129 shares worth $1.19M. The position accounts for 0.1% of the portfolio, ranked #304.

Legato Capital Management first reported a position in INSM in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.96M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Legato Capital Management held 11,129 shares of Insmed worth $1.19M as of Q2 2026.
  • Legato Capital Management sold 28,425 Insmed shares in Q2 2026, an estimated $3.44M.
  • Insmed made up 0.1% of Legato Capital Management's portfolio in Q2 2026, its #304 holding.
  • Legato Capital Management first reported a position in Insmed in Q4 2022 and has held it in 15 quarters since.
  • Legato Capital Management's Insmed position peaked at $6.96M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.